| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/20/2011 | CA2767858A1 Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same |
| 01/20/2011 | CA2765661A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275106A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 01/19/2011 | EP2275091A1 Pharmaceutical compositions comprising adsorbates of an amorphous drug |
| 01/19/2011 | EP1945634B1 Phenylenebisoxazolidine derivatives and their use as anticoagulants |
| 01/19/2011 | EP1773867B1 Proteinaceous compounds and uses therefor |
| 01/19/2011 | EP1448995B1 Assay for screening candidate drugs for the treatment of inflammatory diseases |
| 01/19/2011 | CN1950389B Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 01/19/2011 | CN101952282A Thiazole derivatives used as PI 3 kinase inhibitors |
| 01/19/2011 | CN101952276A 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 01/19/2011 | CN101952249A Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives |
| 01/19/2011 | CN101951897A Use of amidoxime carboxylic acid esters and N-hydroxyguanidine carboxylic acid esters for producing prodrugs |
| 01/19/2011 | CN101948539A IL-18 binding proteins |
| 01/19/2011 | CN101948528A Fibrinolytic activated protein from cantharis, preparation method and application thereof |
| 01/19/2011 | CN101948499A Pseudoginsenoside G1 and extraction method and medicinal applications thereof |
| 01/19/2011 | CN101948439A Extraction method and application to medicine of active alkaloid compounds in cervus nippon temminck |
| 01/19/2011 | CN101947368A Flame-retardant body strengthening safety clothing of nano-element fiber fabric |
| 01/19/2011 | CN101947315A Application of Chinese medicinal bitter apricot seeds in lysozyme sodium alginate microspheres |
| 01/19/2011 | CN101947311A Plasma substitute combination |
| 01/19/2011 | CN101947306A Treatment of T-cell mediated diseases |
| 01/19/2011 | CN101947251A Method for preparing chickpea isoflavone microcapsules |
| 01/19/2011 | CN101947247A Method for preparing ginkgodipyidamolum injection |
| 01/19/2011 | CN101947246A Application of drynaria rhizome for preparing thrombopoietic medicaments as well as product and preparation method |
| 01/19/2011 | CN101947198A Toothpaste special for pregnant women and preparation process thereof |
| 01/19/2011 | CN101946985A Element fabric health-improving protective clothing capable of killing and repelling mosquitoes |
| 01/19/2011 | CN101946856A Compound Chinese medicine micro powder and fish food for fish disease control |
| 01/19/2011 | CN101439072B Application of Chinese medicinal composition in preparing medicament for preventing and treating thrombus |
| 01/19/2011 | CN101088505B Nanometer breviscapine polymer particle preparation and its preparation process |
| 01/18/2011 | US7872142 Coumarin derivatives useful as TNFα inhibitors |
| 01/18/2011 | US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
| 01/18/2011 | US7872019 Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfate |
| 01/18/2011 | US7872011 Inhibition of phosphoinositide 3-kinase β |
| 01/18/2011 | US7871984 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 01/18/2011 | US7871644 Mixture of drug, aminoacrylate polymer and acid |
| 01/18/2011 | US7871608 Reversibly inactivated acidified plasmin |
| 01/18/2011 | CA2436825C Process for the crystallization of (r)- or (s)-lansoprazole |
| 01/18/2011 | CA2331460C Heterocyclic inhibitors of p38 |
| 01/18/2011 | CA2285935C An immunotolerant prothrombin complex preparation |
| 01/18/2011 | CA2212832C Thrombin preparation |
| 01/13/2011 | WO2011006072A2 Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia |
| 01/13/2011 | WO2011005527A2 Ketoreductase-mediated stereoselective route to alpha chloroalcohols |
| 01/13/2011 | WO2011004733A1 Activity enhancer for oxidized protein hydrolase |
| 01/13/2011 | WO2011004697A1 Vaccine for crustacean acute viraemia |
| 01/13/2011 | WO2011004620A1 Cytoprotective agent |
| 01/13/2011 | WO2011004392A1 Crystalline form of prasugrel hydrobromide, preparation and application thereof |
| 01/13/2011 | WO2011004361A2 Long-acting coagulation factors and methods of producing same |
| 01/13/2011 | WO2010130771A3 Compositions and methods for inhibiting expression of glucocorticoid receptor (gcr) genes |
| 01/13/2011 | WO2010116328A3 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines as adp receptor antagonists |
| 01/13/2011 | WO2010115252A9 PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-α MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES |
| 01/13/2011 | WO2010102216A3 Enhancing coagulation or reducing fibrinolysis |
| 01/13/2011 | WO2010078935A3 Solutions for volume therapy |
| 01/13/2011 | US20110009955 Compounds and method for coating surfaces in a hemocompatible manner |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009483 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/13/2011 | US20110009425 Tetrahydrothieno pyridines |
| 01/13/2011 | US20110009409 Dual-acting pyrazole antihypertensive agents |
| 01/13/2011 | US20110009406 Tetrahydro-1h-pyrrolo fused pyridones |
| 01/13/2011 | US20110009389 Imidazole derivative, their production and use |
| 01/13/2011 | US20110009340 Combination of an iron chelator and an immunosuppressant and use thereof |
| 01/13/2011 | US20110009326 Methods or use of lamin b1 nuclear antigen, fragments and compositions thereof, for inhibiting or reducing a thrombotic event |
| 01/13/2011 | US20110009324 Stable Therapeutic Proteins |
| 01/13/2011 | US20110009316 Proteolysis resistant active vegf |
| 01/13/2011 | US20110009312 Albumin Fusion Proteins |
| 01/13/2011 | US20110008459 Universally applicable blood plasma |
| 01/13/2011 | US20110008395 Mixed micelles including amphipathic conjugates of rna agents, and uses thereof |
| 01/13/2011 | US20110008371 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders |
| 01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 01/13/2011 | US20110008341 Polypeptides and methods for making the same |
| 01/13/2011 | US20110008338 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008337 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008336 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008324 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 01/13/2011 | US20110008313 tPA MUTANT IN THE TREATMENT OF ACUTE BRAIN INJURY AND NEURODEGENERATIVE DISORDERS |
| 01/13/2011 | US20110008302 Compositions and methods for immortalizing cells and screening for anti-cancer agents |
| 01/13/2011 | US20110008267 Pharmaceutical and Cosmeceutical Wash-Off Mousse Shampoo Compositions, Processes for Preparing the Same and Uses Thereof |
| 01/13/2011 | US20110008259 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/13/2011 | US20110008251 Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses |
| 01/13/2011 | US20110008250 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008249 Proteins with high immunoreactivity and method for their production |
| 01/13/2011 | CA2804602A1 Codon-optimized factor viii variants and synthetic liver-specific promoter |
| 01/13/2011 | CA2767503A1 Long-acting coagulation factors and methods of producing same |
| 01/12/2011 | EP2272959A1 BMP-11 compositions |
| 01/12/2011 | EP2272826A1 2-mercaptopentancarboxylic acid derivatives, the method for preparing them and the pharmaceutical compositions containing them |
| 01/12/2011 | EP2272822A1 Inhibitor of plasminogen activator inhibitor-1 |
| 01/12/2011 | EP2272565A2 Prevention of thrombus formation and/or stabilization |
| 01/12/2011 | EP2272533A1 Soluble FcyR fusion proteins and methods of use thereof |
| 01/12/2011 | EP2272513A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2272512A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2271367A1 Mineral absorption accelerator and iron deficiency anemia improver or food composition |
| 01/12/2011 | EP2271336A2 Process for extracting coumarins |
| 01/12/2011 | EP1865058B1 Anti-cd-20 monoclonal antibody |
| 01/12/2011 | EP1439863B1 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 01/12/2011 | CN1895260B Sucrose-ferri aseptic powdery injection and its preparation |
| 01/12/2011 | CN1791614B Construct comprising recognition domain of antibody against von Willebrand factor-specific cleaving enzyme |
| 01/12/2011 | CN1772165B Infantile hematogenous granule detection method |
| 01/12/2011 | CN101942040A Method for removing oversulfated chondroitin sulfate in heparin sodium |
| 01/12/2011 | CN101942019A Factor VII or VIIa polypeptide variants |
| 01/12/2011 | CN101942012A Polypeptide for preventing and treating angiogenesis and application thereof |